TechCare signs distribution agreement with MWMedical BV for Novokid Lice treatment device
With a view to addressing a $1.8 billion market globally, and a European market estimated to exceed $500 million, TechCare Corporation a technology company with a revolutionary delivery platform utilizing vapor technology for natural health, wellness and beauty treatments embarked on signing its first distribution agreement with MWMedical B.V., a leading distributor of medical devices in the Netherlands, for TechCare’s Novokid lice treatment device to cater to an estimated $500 million European market as well.
The Netherlands represents the first success for TechCare among 28 European countries that TechCare is able to sell to following the receipt of CE Approval in August of last year. As the Netherlands is one of the most densely populated countries in the world, with 17.04 million people living in close proximity, lice management is very important in this country.
According to Zvi Yemini, Chairman of TechCare Corp., “TechCare is delighted to announce its first agreement for Novokid with MWMedical to provide TechCare’s leading technology with the broad representation of this organization in Netherlands. We are proud that after a wide-ranging evaluation, MWMedical has selected TechCare’s technology. Beginning in February, the Dutch market will now have wide access to the superior Novokid lice treatment device.”
Shlomi Arbel, CEO of TechCare commented, “We are delighted that Novokid will launch in the Dutch market at the leading consumer event of the year. Our plans are to maximize our relationship with our distribution partner, and to leverage this momentum to expand to the additional 27 countries available to TechCare under its CE Mark.”
Image Source: TechCare Corp